Companies Dominating the HER2 Testing Market
- Agilent Technologies, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific
- Roche
- Empire Genomics Inc.
- Abnova Corporation
- Eli Lilly and Company
- Oxford Gene Technology IP Limited
- Genetech
- Genemed Technologies Inc.
- PERKINELMER Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of HER2 testing is assessed at USD 166.34 million.
The HER2 testing market size was over USD 156.75 million in 2024 and is anticipated to cross USD 387.03 million by 2037, witnessing more than 7.2% CAGR during the forecast period i.e., between 2025-2037. Increasing research and development in cancer diagnostic technologies and the popularity of HER2 testing for breast cancer screening will drive the market growth.
North America industry is expected to account for largest revenue share of 44% by 2037, impelled by high acceptance rate and greater product penetration in the region.
The major players in the market are Thermo Fisher Scientific, Roche, Empire Genomics Inc., Abnova Corporation, Eli Lilly and Company, Oxford Gene Technology IP Limited, Genetech, Genemed Technologies Inc., PERKINELMER Inc., and others.
